ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma

Tang, Wenhui; Xu, Ningbo; Zhou, Jian; He, Zhenyan; Lenahan, Cameron; Wang, Chenyang; Ji, Huangyi; Liu, Boyang; Zou, Yujiao; Zeng, Huijun; Guo, Hongbo*南方医科大学; 汕头大学; 郑州大学; 1
Cell Death Discovery2022-12-24DOI: 10.1038/s41420-022-01286-w
13被引4阅读
引用收藏
分享

摘要

N6-methylation of adenosine (m6A) is one of the most frequent chemical modifications in eukaryotic RNAs and plays a vital role in tumorigenesis and progression. Recently, emerging studies have shown that m6A modification by ALKBH5 was associated with immunotherapy response in various types of cancer. However, whether m6A demethylases ALKBH5 participate in regulating the tumor immune microenvironment and the efficacy of immunotherapy in glioblastoma remain unknown. Here, we found that deletion of ALKBH5 significantly inhibited the growth of glioma allografts, rescued the antitumoral immune response, and increased cytotoxic lymphocyte infiltration and proinflammatory cytokines in CSF while significantly suppressing PD-L1 protein expression. m6A-methylated RNA immunoprecipitation sequencing and RNA sequencing identify ZDDHC3 as the direct target of ALKBH5. Mechanically, ALKBH5 deficiency impairs the YTHDF2-mediated stability of ZDHHC3 mRNA, thereby suppressing PD-L1 expression by accelerating PD-L1 degradation in glioma. In addition, genetic deletion or pharmacological inhibition of ALKBH5 with IOX1 enhances the therapeutic efficacy of anti-PD-1 treatment in preclinical mice models. These data suggest that the combination of anti-PD-1 therapy and ALKBH5 inhibition may be a promising treatment strategy in glioma.

学科与关键词

关键词
RNA METHYLATIONEXPRESSIONNIVOLUMABPD-L1CMTM6
相关
加载中…
  • Decreased RNA m6A methylation enhances the process of the epithelial mesenchymal transition and vasculogenic mimicry in glioblastoma
    Tao, Min; Li, Xiaoyu; He, Lei; Rong, Xiaoming; Wang, Hongxuan; Pan, Jingrui; Lu, Zijing; Zhang, Xiaoni; Peng, Ying*American Journal of Cancer Research, 2022, 12(2): 893-+.被引 19
  • Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses
    Yuan, Feng; Cai, Xiangming; Cong, Zixiang; Wang, Yingshuai; Geng, Yuanming; Aili, Yiliyaer; Du, Chaonan; Zhu, Junhao; Yang, Jin; Tang, Chao; Zhang, Aifeng; Zhao, Sheng; Ma, Chiyuan*Frontiers in Immunology, 2022, 13: 798583.被引 7
  • RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D
    Wu, Yingmin; Chen, Zhuojia; Xie, Guoyou; Zhang, Haisheng; Wang, Zhaotong; Zhou, Jiawang; Chen, Feng; Li, Jiexin; Chen, Likun; Niu, Hongxin; Wang, Hongsheng*PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119(28): e2119038119.被引 22
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Death Discovery
发表日期
2022-12-24
卷期
第 8 卷, 第 1 期
页码
497
DOI
10.1038/s41420-022-01286-w
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; National Natural Science Foundation of Guangdong Province; Guangdong Provincial Clinical Medical Centre for Neurosurgery; [82073193]; [81874079]; [82102946]; [2017A030308001]; [2018A030310422]; [2013B020400005]

作者

  • T

    Tang, Wenhui (第一作者)

    southern med univ

  • X

    Xu, Ningbo

    southern med univ

查看全部 11 位作者收起作者
  • Z

    Zhou, Jian

    southern med univ

  • H

    He, Zhenyan

    zhengzhou univ

  • L

    Lenahan, Cameron

  • W

    Wang, Chenyang

    southern med univ

  • J

    Ji, Huangyi

    1 · shantou univ

  • L

    Liu, Boyang

    southern med univ

  • Z

    Zou, Yujiao

    southern med univ

  • Z

    Zeng, Huijun

    southern med univ

  • G

    Guo, Hongbo (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417